TIL treatment Group:TIL infusion

3 trials

Sponsors

The Affiliated Hospital of Xuzhou Medical University, the First Affiliated Hospital of Soochow University, The Affiliated Hospital of Qingdao University

Conditions

Advanced Solid Tumor

Early Phase 1

Study on the safety and efficacy of autogenous tumor infiltrates lymphocytes (HS-IT101) in the treatment of patients with advanced solid tumor

Active, not recruitingChiCTR2200063835

The Affiliated Hospital of Qingdao UniversityAdvanced Solid Tumor

Start: 2022-09-16Updated: 2023-04-17

Phase 1

A single center, single arm, phase I trial of autologous tumor infiltrating lymphocytes (TIL) in the treatment of advanced solid tumor

RecruitingChiCTR2100045007

The Affiliated Hospital of Xuzhou Medical UniversityAdvanced Solid Tumor

Start: 2021-04-06Updated: 2021-11-08

A single center, single arm, phase I trial of autologous tumor infiltrating lymphocytes (TIL) in the treatment of advanced solid tumor

RecruitingChiCTR2100054763

the First Affiliated Hospital of Soochow UniversityAdvanced Solid Tumor

Start: 2021-12-31Updated: 2022-12-05